Showing results (191-200 of 361) with videos related to

Sort By:
Pageof 37
Gynecologic Oncology|February 27, 2013
A phase II evaluation of gefitinib in the treatment of persistent or recurrent endometrial cancer: a Gynecologic Oncology Group studyKimberly K Leslie, Michael W Sill, Edgar Fischer, et al.
Gynecologic Oncology|October 27, 2009
Regulation of miR-200 family microRNAs and ZEB transcription factors in ovarian cancer: evidence supporting a mesothelial-to-epithelial transitionAusra Bendoraite, Emily C Knouf, Kavita S Garg, et al.
Biorxiv : the Preprint Server for Biology|April 10, 2026
Comparative single-cell atlases reveal injury-driven tubal epithelial regeneration as a window for ovarian carcinoma initiationCoulter Q Ralston, Andrea Flesken-Nikitin, Dah-Jiun Fu, et al.
Clinical Breast Cancer|June 27, 2007
Large genomic rearrangement in BRCA1 and BRCA2 and clinical characteristics of men with breast cancer in the United StatesJulia Tchou, M Renee Ward, Patricia Volpe, et al.
Cancer Chemotherapy and Pharmacology|May 30, 2024
Pre-treatment amino acids and risk of paclitaxel-induced peripheral neuropathy in SWOG S0221Ciao-Sin Chen, Gary Zirpoli, G Thomas Budd, et al.
Research Square|September 11, 2023
Pre-treatment Amino Acids and Risk of Paclitaxel-induced Peripheral Neuropathy in SWOG S0221Ciao-Sin Chen, Gary Zirpoli, G Thomas Budd, et al.
The American Journal of Pathology|February 13, 2002
Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumorsIsamu Okamoto, Hiromasa Tsuiki, Lawrence C Kenyon, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 30, 2003
Parkin, a gene implicated in autosomal recessive juvenile parkinsonism, is a candidate tumor suppressor gene on chromosome 6q25-q27Rossano Cesari, Eric S Martin, George A Calin, et al.
Nature Communications|October 14, 2016
Macrophage-derived extracellular vesicle-packaged WNTs rescue intestinal stem cells and enhance survival after radiation injurySubhrajit Saha, Evelyn Aranda, Yoku Hayakawa, et al.
Cell Reports. Medicine|January 26, 2023
Cabozantinib plus durvalumab in advanced gastroesophageal cancer and other gastrointestinal malignancies: Phase Ib CAMILLA trial resultsAnwaar Saeed, Robin Park, Junqiang Dai, et al.
Pageof 37